- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06167239
Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases
Effect of Ventilator Trigger Sensitivity Adjustment Versus Threshold Inspiratory Muscle Training on Arterial Blood Gases in Mechanically Ventilated Patients, a Randomized Clinical Trail
Study Overview
Status
Conditions
Detailed Description
Failed extubations are not uncommon in most ICUs, the failure rate ranging from 2 to 20%. Since failed extubation is associated with greater hospital morbidity and mortality and longer length of stay, it is imperative to identify screening techniques that minimize the number of failed extubations.
Many studies have been done on the effect of IMT by threshold IMT and adjustment of mechanical ventilator trigger separately, thereby, it is rational to compare between two methods of training to know which is more effective to help in weaning process through its effect on ABGs.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elmasry
- Phone Number: 01005587119
- Email: egydodo@rocketmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Kasr Al Ainy School of Medicine
-
Contact:
- School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Difficult to wean Guillain barre patients who have been on MV for at least 48 hours. Difficult to wean subjects have been defined as those who fail the first spontaneous breathing trial (SBT)and may require up to 3 SBTs or up to 7 d from the first attempt to achieve successful weaning (B´eduneau G. et al.,2017) and (Annia F. et al.,2019).
- Age: >18 years.
- Both sexes will be included.
- Ventilator mode: Pressure support mode with FiO2≤ 0.5, positive end expiratory pressure (PEEP) will be<8-10cm/H2Oand respiratory rate < 25.
- Conscious oriented patient with Glasgow coma score ≥13.
- Alertness will be titrated to a Riker Sedation Agitation Score of 4.
- PH>7.25, arterial oxygen saturation >90%.
- Cardiovascular stability.
- Maximal inspiratory pressure from 15 to 30 cm H2O and able to trigger spontaneous breaths on ventilator.
Exclusion Criteria:
- Persistent hemodynamic instability as life threatening arrhythmias, acute heart failure.
- Severe breathlessness, when spontaneously breathing.
- Any progressive neuromuscular disease that would interfere with responding to inspiratory muscle training (non-stationary course).
- Spinal cord injury.
- Skeletal pathology (scoliosis, flail chest, spinal instrumentation) that would seriously impair the movement of the chest wall and ribs.
- Patients on heavy sedation and respiratory muscle paralysis.
- High peak airway pressure (barotraumas).
- BMI ≥ 40.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Threshold inspiratory muscle trainer
Training of the inspiratory muscles by threshold inspiratory muscle trainer.
|
New techniques to train inspiratory muscles in mechanically ventilated patients
|
|
Experimental: Ventilator pressure setting inspiratory muscle training
Training of the inspiratory muscles by ventilator pressure setting.
|
New techniques to train inspiratory muscles in mechanically ventilated patients
|
|
No Intervention: Traditional treatment
Only prescribed medical treatment programme
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PH
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure PH
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
PaO2
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure partial pressure of oxygen
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
PaCO2
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure partial pressure of carbon dioxide
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
HCO3
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure bicarbonate
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rapid shallow breathing index
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure respiratory endurance
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
The Horowitz index
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure PaO2 /FiO2 ratio
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
Glasgow coma scale
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
To measure level of consciousness
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
Riker Sedation-Agitation Scale
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
Arousal/sedation assessment
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
Respiratory rate
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
Number of breath cycles per minute
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
Minute ventilation
Time Frame: Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
The amount of air that enters the lungs per minute.
|
Pre intervention and immediate post intervention, through study completion, an average of two weeks
|
|
Weaning success rate
Time Frame: post intervention at the end of the study, an average of two weeks
|
Number of patients weaning from MV
|
post intervention at the end of the study, an average of two weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Elmasry, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Post-Infectious Disorders
- Nervous System Diseases
- Pathologic Processes
- Neuromuscular Diseases
- Chronic Disease
- Disease Attributes
- Autoimmune Diseases
- Immune System Diseases
- Peripheral Nervous System Diseases
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Polyneuropathies
- Polyradiculoneuropathy
- Guillain-Barre Syndrome
Other Study ID Numbers
- P.T.REC/012/004784
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Guillain-Barre Syndrome
-
Mansoura University HospitalUnknownGuillain Barre SyndromeEgypt
-
Mansoura University Children HospitalCompletedGuillain Barre SyndromeEgypt
-
Ning Wang, MD., PhD.Recruiting
-
Zhongming QiuNot yet recruitingGuillain-Barre Syndrome (GBS)
-
University Hospital, Basel, SwitzerlandRecruitingGuillain-Barre Syndrome (GBS)Switzerland
-
Meir Medical CenterRecruitingMechanical Ventilation | Guillain Barre SyndromeIsrael
-
Hoffmann-La RocheChugai Pharmaceutical Co., Ltd. (Sponsor in Taiwan and Japan)Withdrawn
-
Cellenkos, Inc.Withdrawn
-
Japan Blood Products OrganizationCompleted
-
National Taiwan University HospitalUnknownGuillain Barré SyndromeTaiwan
Clinical Trials on Threshold inspiratory muscle trainer or ventilator pressure setting inspiratory muscle training techniques
-
National Taiwan University HospitalCompletedAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseTaiwan
-
Boston Children's HospitalCompletedCongenital Heart Disease | Single VentricleUnited States
-
Cairo UniversityCompleted
-
Guangzhou Institute of Respiratory DiseaseCompletedChronic Obstructive Pulmonary DiseaseChina
-
National Cheng-Kung University HospitalCompletedObstructive Sleep ApneaTaiwan
-
Guangzhou Institute of Respiratory DiseaseCompletedChronic Obstructive Pulmonary Disease
-
Cairo UniversityCompleted
-
Clínica BasileaNot yet recruitingPhysical Therapy Modalities, Respiratory Muscles, Maximal Respiratory Pressures, Breathing Exercise
-
Universitas PadjadjaranDr. Hasan Sadikin General Hospital, Bandung, IndonesiaNot yet recruitingChronic Obstructive Pulmonary Disease (COPD) | Diaphragm Dysfunction